Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists

Area of Science:

• Orthopedic surgery
• Infectious diseases
• Biomedical engineering

Background:

• Prosthetic joint infections (PJIs) complicate 1.5%-2.5% of primary hip and knee arthroplasties.
• PJIs are associated with a mortality rate up to 2.5% and substantial temporary morbidity, including loss of mobility.
• The economic burden of a single PJI episode exceeds $50,000, excluding lost wages.

Purpose of the Study:

• To review the incidence, risk factors, clinical presentation, causative organisms, and management strategies for prosthetic joint infections.
• To compare the efficacy of different surgical interventions for PJI treatment.
• To highlight optimal approaches for managing PJI to minimize recurrence.

Main Methods:

• Literature review of studies on prosthetic joint infections.
• Analysis of risk factors, symptoms, and common pathogens.
• Evaluation of surgical techniques including two-stage revision, single-stage revision, and debridement with prosthesis retention.
• Assessment of adjunctive therapies like antibiotic suppression and arthrodesis.

Main Results:

• Staphylococcus species are the most frequently isolated organisms from PJI sites.
• Two-stage revision surgery demonstrates superior outcomes compared to single-stage revision or debridement with prosthesis retention.
• Long-term antibiotic suppression or arthrodesis are viable options for high-risk patients.
• Recurrent infection rates can be maintained below 10% with optimal management strategies.

Conclusions:

• Effective management of PJIs requires a thorough understanding of risk factors and causative agents.
• Two-stage revision is the preferred surgical approach for most PJI cases.
• Tailored treatment strategies, including conservative measures for frail patients, are crucial for successful PJI management and reducing recurrence.